Harris AL - Search Results

1

Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin.

Lord SR, Collins JM, Cheng WC, Haider S, Wigfield S, Gaude E, Fielding BA, Pinnick KE, Harjes U, Segaran A, Jha P, Hoefler G, Pollak MN, Thompson AM, Roy PG, English R, Adams RF, Frezza C, Buffa FM, Karpe F, Harris AL. Lord SR, et al. Among authors: harris al. Br J Cancer. 2020 Jan;122(2):258-265. doi: 10.1038/s41416-019-0665-5. Epub 2019 Dec 10. Br J Cancer. 2020. PMID: 31819193 Free PMC article. Clinical Trial.

2

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.

Wright C, Nicholson S, Angus B, Sainsbury JR, Farndon J, Cairns J, Harris AL, Horne CH. Wright C, et al. Among authors: harris al. Br J Cancer. 1992 Jan;65(1):118-21. doi: 10.1038/bjc.1992.22. Br J Cancer. 1992. PMID: 1346366 Free PMC article.

3

Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases.

Wright C, Cairns J, Cantwell BJ, Cattan AR, Hall AG, Harris AL, Horne CH. Wright C, et al. Among authors: harris al. Br J Cancer. 1992 Feb;65(2):271-4. doi: 10.1038/bjc.1992.54. Br J Cancer. 1992. PMID: 1346748 Free PMC article.

4

High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines.

Stuart NS, Philip P, Harris AL, Tonkin K, Houlbrook S, Kirk J, Lien EA, Carmichael J. Stuart NS, et al. Among authors: harris al. Br J Cancer. 1992 Nov;66(5):833-9. doi: 10.1038/bjc.1992.369. Br J Cancer. 1992. PMID: 1358168 Free PMC article. Clinical Trial.

5

p53 expression in human breast cancer.

Harris AL. Harris AL. Adv Cancer Res. 1992;59:69-88. doi: 10.1016/s0065-230x(08)60303-6. Adv Cancer Res. 1992. PMID: 1519492 Review. No abstract available.

6

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.

Gullick WJ, Love SB, Wright C, Barnes DM, Gusterson B, Harris AL, Altman DG. Gullick WJ, et al. Among authors: harris al. Br J Cancer. 1991 Mar;63(3):434-8. doi: 10.1038/bjc.1991.100. Br J Cancer. 1991. PMID: 1672253 Free PMC article.

7

A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.

Philip PA, Joel S, Monkman SC, Dolega-Ossowski E, Tonkin K, Carmichael J, Idle JR, Harris AL. Philip PA, et al. Among authors: harris al. Br J Cancer. 1992 Feb;65(2):267-70. doi: 10.1038/bjc.1992.53. Br J Cancer. 1992. PMID: 1739628 Free PMC article. Clinical Trial.

8

Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.

Millward MJ, Cantwell BM, Dowsett M, Carmichael J, Harris AL. Millward MJ, et al. Among authors: harris al. Br J Cancer. 1991 May;63(5):763-4. doi: 10.1038/bjc.1991.170. Br J Cancer. 1991. PMID: 1903951 Free PMC article. Clinical Trial. No abstract available.

9

Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.

Nutt JE, Harris AL, Lunec J. Nutt JE, et al. Among authors: harris al. Br J Cancer. 1991 Oct;64(4):671-6. doi: 10.1038/bjc.1991.379. Br J Cancer. 1991. PMID: 1911215 Free PMC article.

10

Reversal of acquired resistance to adriamycin in CHO cells by tamoxifen and 4-hydroxy tamoxifen: role of drug interaction with alpha 1 acid glycoprotein.

Chatterjee M, Harris AL. Chatterjee M, et al. Among authors: harris al. Br J Cancer. 1990 Nov;62(5):712-7. doi: 10.1038/bjc.1990.365. Br J Cancer. 1990. PMID: 2245162 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,286 results

Search Page

Filters